Trend
DailyDowntrend (starting)
4 hourSymmetric Triangle
1 hourDescending Triangle
15 minBullish
5 minStrong Bearish
Daily trend turns up above $22.00
Key levels
Resistance$13.82
Resistance$13.12
Support$12.21
Latest news & SEC filings
No headlines in the last 90 days.
This Australian company develops off-the-shelf cell-based medicines derived from donor bone marrow. Its approved therapy, Ryoncil, is used for children with a serious complication after stem cell transplants, while other candidates target lower back pain and heart failure. It runs research and clinical programs in Australia and the United States, working with hospitals, transplant centers and research partners.
Based on the company's 20-F filed Aug 27, 2026.
Nasdaq · Healthcare
SEPT Low Target
$39.00
SEPT Mid Target
$39.00
SEPT High Target
$39.00
Analyst Consensus
$39.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MESO.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$39.00
27
Moat Score
NONE
5/9
Piotroski Score
54.6
Altman Z-Score
Insider Signal
BUYING
10 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
191.4%
3yr Revenue CAGR
19.0%
EPS Growth YoY
5.05%
FCF Growth YoY
-3.9%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for MESO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:32:07 | $13.49 | 1,000 | $$13K | BUY |
| 21:27:05 | $13.10 | 5,184 | $$68K | SELL |
| 19:29:15 | $13.11 | 1,000 | $$13K | MIDPOINT |
| 19:01:18 | $13.12 | 1,523 | $$20K | SELL |
| 18:15:31 | $13.16 | 1,000 | $$13K | SELL |
5 dark pool trades shown · $$128K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for MESOBLAST LTD (MESO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MESOBLAST LTD (MESO) is at $13.10, down 4.03% (-$0.55) at the Nov 12, 2026 close.
The average analyst price target for MESO is $39.00, ranging from $39 to $39, based on 1 analysts.
Analyst ratings for MESO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
MESO last reported on Aug 26, 2026: EPS -$0.13 vs -$0.11 expected — a miss of 23.2%.
MESO does not currently pay a dividend.
MESOBLAST LTD reported $122M of debt and $162M of cash (Jun 30, 2025).
Support: $12.21. Resistance: $13.12, $13.82, $14.56.
Insider activity: BUYING, 10 buys and 0 sells in the last 90 days.